FLORENCE, Ky., June 30, 2009 (GLOBE NEWSWIRE) -- ImmuDyne (Pink Sheets:IMMD), continuing to build its intellectual property and leadership role in Beta Glucan technology, today announced that the Company recently received an issue notice from the U.S. Patent Office. ImmuDyne's patent application entitled, Methods of Purifying Beta Glucans (Amended), has now been issued as U.S. Patent 7,750,584.
ImmuDyne shares trade under the ticker symbol IMMD (PK) and the Company can be found on the web at www.immudyne.com